Beijing YiCheng Bioelectronics Technology Co. Ltd., China’s leading manufacturer of OTC blood glucose monitoring devices, closed a $10.3 million Series A funding, raising money from Sequoia Capital and PreIPO Capital. Sequoia Capital China runs a $1 billion fund, and PreIPO Capital has been involved in China private equity and venture capital investing since 1999. More details...